ATRX is a regulator of therapy induced senescence in human cells

Therapy induced senescence (TIS) is a growth suppressive program activated by cytostatic agents in some cancer cells. Here the authors show that the chromatin remodeling enzyme ATRX is a regulator of TIS and drives cells into this state via multiple mechanisms.

Guardado en:
Detalles Bibliográficos
Autores principales: Marta Kovatcheva, Will Liao, Mary E. Klein, Nicolas Robine, Heather Geiger, Aimee M. Crago, Mark A. Dickson, William D. Tap, Samuel Singer, Andrew Koff
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/7f628acc50d64801af6befbeedb96ee3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7f628acc50d64801af6befbeedb96ee3
record_format dspace
spelling oai:doaj.org-article:7f628acc50d64801af6befbeedb96ee32021-12-02T15:38:33ZATRX is a regulator of therapy induced senescence in human cells10.1038/s41467-017-00540-52041-1723https://doaj.org/article/7f628acc50d64801af6befbeedb96ee32017-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00540-5https://doaj.org/toc/2041-1723Therapy induced senescence (TIS) is a growth suppressive program activated by cytostatic agents in some cancer cells. Here the authors show that the chromatin remodeling enzyme ATRX is a regulator of TIS and drives cells into this state via multiple mechanisms.Marta KovatchevaWill LiaoMary E. KleinNicolas RobineHeather GeigerAimee M. CragoMark A. DicksonWilliam D. TapSamuel SingerAndrew KoffNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-16 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Marta Kovatcheva
Will Liao
Mary E. Klein
Nicolas Robine
Heather Geiger
Aimee M. Crago
Mark A. Dickson
William D. Tap
Samuel Singer
Andrew Koff
ATRX is a regulator of therapy induced senescence in human cells
description Therapy induced senescence (TIS) is a growth suppressive program activated by cytostatic agents in some cancer cells. Here the authors show that the chromatin remodeling enzyme ATRX is a regulator of TIS and drives cells into this state via multiple mechanisms.
format article
author Marta Kovatcheva
Will Liao
Mary E. Klein
Nicolas Robine
Heather Geiger
Aimee M. Crago
Mark A. Dickson
William D. Tap
Samuel Singer
Andrew Koff
author_facet Marta Kovatcheva
Will Liao
Mary E. Klein
Nicolas Robine
Heather Geiger
Aimee M. Crago
Mark A. Dickson
William D. Tap
Samuel Singer
Andrew Koff
author_sort Marta Kovatcheva
title ATRX is a regulator of therapy induced senescence in human cells
title_short ATRX is a regulator of therapy induced senescence in human cells
title_full ATRX is a regulator of therapy induced senescence in human cells
title_fullStr ATRX is a regulator of therapy induced senescence in human cells
title_full_unstemmed ATRX is a regulator of therapy induced senescence in human cells
title_sort atrx is a regulator of therapy induced senescence in human cells
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/7f628acc50d64801af6befbeedb96ee3
work_keys_str_mv AT martakovatcheva atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT willliao atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT maryeklein atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT nicolasrobine atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT heathergeiger atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT aimeemcrago atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT markadickson atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT williamdtap atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT samuelsinger atrxisaregulatoroftherapyinducedsenescenceinhumancells
AT andrewkoff atrxisaregulatoroftherapyinducedsenescenceinhumancells
_version_ 1718386183135821824